Dodge & Cox Boosts Holdings in Zimmer Biomet

Investment firm increases stake in medical equipment provider by 5.1%

Mar. 14, 2026 at 8:09am

Got story updates? Submit your updates here. ›

Dodge & Cox, a major investment firm, has increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 5.1% during the third quarter, according to a recent SEC filing. The firm now owns 23,216,173 shares of the medical equipment provider's stock, representing approximately 11.71% of Zimmer Biomet's outstanding shares.

Why it matters

Zimmer Biomet is a leading global manufacturer of orthopedic implants and surgical products. Institutional investors like Dodge & Cox closely monitor and adjust their positions in major medical device companies, as changes in ownership can signal broader market trends and investor sentiment around the industry.

The details

In its 13F filing, Dodge & Cox reported acquiring an additional 1,118,710 shares of Zimmer Biomet during the third quarter. This increased the firm's total stake in the company to 23,216,173 shares, worth approximately $2.29 billion based on Zimmer Biomet's stock price at the end of the quarter.

  • Dodge & Cox increased its stake in Zimmer Biomet during the third quarter of 2026.

The players

Dodge & Cox

A major investment management firm that oversees over $300 billion in assets.

Zimmer Biomet Holdings, Inc.

A global medical device company focused on musculoskeletal healthcare, headquartered in Warsaw, Indiana.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

Dodge & Cox's increased stake in Zimmer Biomet suggests the investment firm sees long-term growth potential in the medical device maker, which could signal broader investor confidence in the orthopedics market.